KTRA

Kintara Therapeutics Inc
6.99
0.00 (0.00%)
Company Name Stock Ticker Symbol Market Type
Kintara Therapeutics Inc KTRA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 6.99 04:00:08
Open Price Low Price High Price Close Price Prev Close
6.99
more quote information »

Recent News

Date Time Source Heading
2/02/20239:58IHNWFeaturedGoldshore Intersects 9.46 g/t Au over 7.45m in the Southwest Zone Widths of Mineralized System Expanded Significantly.
2/02/20239:30IHNWFeaturedHempacco and Snoop Dogg Create Joint Venture to Launch Consumer Goods Powerhouse of Hemp and Hemp-Derived Products
2/02/20237:03IHNWFeaturedAmerican Green (OTC:ERBB) Receives Equipment Lease Funding for its 40K s.f. Cypress Chill Cannabis Grow
12/30/202216:58VWIs Kintara Therapeutics A Hidden Gem?
12/05/202208:01EDGARCurrent Report Filing (8-k)
11/28/202212:42TRMNKintara Therapeutics Shares (NASDAQ: KTRA) Surge after..
11/20/202208:25TRMNKintara Therapeutics (KTRA) Receives a Hold from Dawson..
11/14/202208:02EDGARCurrent Report Filing (8-k)
11/11/202211:25TRMNMaxim Group Keeps Their Hold Rating on Kintara Therapeutics..
11/09/202217:26EDGARCurrent Report Filing (8-k)
10/19/202210:29APSBiotech Stock Catches Premarket Bid On Wednesday
10/19/202208:31EDGARCurrent Report Filing (8-k)
9/27/202216:37EDGARSecurities Registration: Employee Benefit Plan (s-8)
9/27/202208:31EDGARCurrent Report Filing (8-k)
9/27/202208:15PRNUSKintara Therapeutics Announces Fiscal 2022 Financial Results..
9/27/202208:03EDGARAnnual Report (10-k)
9/08/202207:00PRNUSKintara Therapeutics Announces Three Abstracts Have Been..
8/09/202209:00PRNUSKintara Therapeutics Receives Study May Proceed Letter from..
8/03/202216:31EDGARStatement of Changes in Beneficial Ownership (4)
8/03/202216:31EDGARStatement of Changes in Beneficial Ownership (4)
8/03/202216:31EDGARStatement of Changes in Beneficial Ownership (4)
8/03/202216:07EDGARCurrent Report Filing (8-k)
8/03/202209:08EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
8/03/202208:30PRNUSKintara Therapeutics Enters Into Equity Purchase Agreement..
7/05/202216:06EDGARStatement of Changes in Beneficial Ownership (4)
7/05/202216:06EDGARStatement of Changes in Beneficial Ownership (4)
7/05/202216:06EDGARStatement of Changes in Beneficial Ownership (4)
6/22/202216:16EDGARCurrent Report Filing (8-k)
6/21/202208:00PRNUSKintara Therapeutics to Present at the Alliance Global..
6/16/202209:00EDGARCurrent Report Filing (8-k)
6/15/202209:00PRNUSKintara Therapeutics Granted Fast Track Designation from the..
6/10/202209:00PRNUSKintara Therapeutics to Present at the JMP Securities Life..
6/03/202209:17EDGARCurrent Report Filing (8-k)
6/03/202209:00PRNUSKintara Granted 180-Day Extension to Meet Nasdaq Minimum Bid..
5/27/202209:30PRNUSKintara Announces First European Site Activation in..
5/24/202208:32EDGARCurrent Report Filing (8-k)
5/13/202208:32EDGARQuarterly Report (10-q)
5/13/202208:16EDGARCurrent Report Filing (8-k)
5/13/202208:00PRNUSKintara Therapeutics Announces Fiscal 2022 Third Quarter..
5/06/202216:12EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
5/06/202216:07EDGARProxy Statement (definitive) (def 14a)
4/26/202216:17EDGARProxy Statement - Notice of Shareholders Meeting..
4/26/202207:30PRNUSKintara Therapeutics to Present at the Planet MicroCap..
4/18/202216:38EDGARCurrent Report Filing (8-k)
4/14/202216:05PRNUSKintara Announces Closing of $8.6 Million Registered Direct..
4/13/202216:17EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
4/13/202216:16EDGARCurrent Report Filing (8-k)
4/12/202208:30PRNUSKintara Announces $8.6 Million Registered Direct Offering..
4/11/202214:30PRNUSKintara Therapeutics Presents Data at the 2022 American..
3/22/202208:00PRNUSKintara Therapeutics to Present at the Maxim Group 2022..
3/20/202209:25TRMNDawson James Thinks Kintara Therapeutics’ Stock is Going to..
3/15/202207:00PRNUSKintara Therapeutics Announces Data Presentation at the 2022..
2/11/202208:54SEEKKintara Therapeutics GAAP EPS of -$0.12 beats by $0.05